Alexion

Q4 Biotech Earnings Preview
TheStreet.com
Mon, 01/27/14 - 11:53 am
earnings
Amgen
Biogen Idec
Vertex Pharmaceuticals
Celgene
Alexion
Prospects Bright at Alexion Pharma
Yahoo/Zacks.com
Thu, 01/16/14 - 10:54 am
Alexion
Biogen, Celgene Lead 5 Top Large-Cap Drugmakers
Investors.com
Wed, 01/15/14 - 10:06 am
Biogen Idec
Celgene
Alexion
Actavis
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
Tue, 01/14/14 - 09:07 am
biotech
M&A
Alexion
Biomarin
Incyte
Medivation
Idenix
Insmed
InterMune
Puma Biotechnology
Vertex Pharmaceuticals
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
JPMHC 2014
GSK
Intercept Pharma
Acorda Therapeutics
Cell Therapeutics
Novartis
Sanofi
Alnylam
Idenix
Alexion
Galena Biopharma
Incyte
Clovis Oncology
Dendreon
Merck
Arena Pharmaceuticals
What’s Next for Biotech?
Barron's
Fri, 01/10/14 - 06:47 pm
Celgene
Alexion
Incyte
Biomarin
3 Health Care Stocks Dragging The Sector Down
TheStreet.com
Fri, 01/3/14 - 12:54 pm
Illumina
Alexion
Regeneron
3 Biotech Stocks Spiking on Big Volume
TheStreet.com
Thu, 12/19/13 - 08:11 am
NPS Pharmaceuticals
Halozyme
Alexion
Soliris® (eculizumab) Inhibits TMA and Improves Renal Function in Pediatric and Adult Patients with atypical Hemolytic Uremic Syndrome (aHUS)
Yahoo/BusinessWire
Sat, 11/9/13 - 12:29 pm
Soliris
atypical hemolytic uremic syndrome
Alexion
5 Revenue-Growing Biotechs With Attractive Fundamentals
Seeking Alpha
Thu, 11/7/13 - 09:49 am
Jazz Pharmaceuticals
Alexion
Questcor
Celgene
Regeneron
Alexion Reports Third Quarter 2013 Results
Yahoo
Thu, 10/24/13 - 08:41 am
Alexion
earnings
Alexion reports data from Phase 2 study of asfotase alfa
Yahoo/Fly on the Wall
Mon, 09/23/13 - 09:39 am
Alexion
asfotase alfa
hypophosphatasia
Have These 4 Biotechs Peaked?
Motley Fool
Mon, 09/16/13 - 11:04 am
biotech
Alexion
Pharmacyclics
Aegerion
Raptor Pharmaceuticals
4 Healthcare Stock Stories Making a Buzz On Friday
Wall St Cheat Sheet
Sat, 09/14/13 - 10:44 am
Teva Pharmaceuticals
Ariad Pharmaceuticals
Alexion
Galena Biopharma
Data from Alexion's Soliris Study
Yahoo/Zacks
Sat, 09/14/13 - 10:41 am
Alexion
acute antibody-mediated rejection
kidney transplants
transplant
Soliris
Alexion's Soliris receives marketing approval in Japan
The Fly on the Wall
Fri, 09/13/13 - 09:09 am
Japan
Soliris
Alexion
atypical hemolytic uremic syndrome
Pharma chief casts doubt on Roche interest in Alexion
Fierce Pharma
Thu, 09/12/13 - 10:30 am
Alexion
Roche
M&A
Daniel O'Day
Biogen Tops 4 Big Biotechs For A Healthy Portfolio
Investors.com
Wed, 09/11/13 - 08:52 am
Biogen Idec
Celgene
Alexion
Regeneron
Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Seeking Alpha
Tue, 09/3/13 - 04:19 pm
biotech
M&A
ONYX Pharmaceuticals
Alexion
Biomarin
Incyte
Medivation
Pharmacyclics
Regeneron
Seattle Genetics
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa

Pages